SlideShare a Scribd company logo
1 of 66
DryEye
1
2
Learning Objectives
Attheendofthisclassthestudentsshallbeableto:
•Definedryeyedisease.
• Understand predisposing andaetiological factors
responsible for dryeyedisease
• Comprehendclinical features andtests for theabove
condition
• Understand fundamentals of managing dryeye
depending ontheseverity of disease
3
What is Dry Eye Disease?
•Dry eyedisease(DED)is acondition caused
by many factors that result in inflammation of
theeyeandtear-producingglands.
•Inflammationcandecreasetheability of the
eyeto producenormaltearsthatprotectthe
surfaceoftheeyeandkeepit moistand
lubricated.
4
Definition
Dryeyeis notatrivial complaint. It cancausesignificant
discomfort andaffect quality of life significantly.
 In 1995theNational EyeInstitute defined dryeye
disease(DED) as“ adisorderof thetear film dueto tear
deficiencyorexcessivetear evaporation whichcauses
damageto theinterpalpebral ocular surfaceandis
associated with symptomsof ocular discomfort”.
5
Definition
In 2007theInternational DryEyeWorkshop
defined it as
“ amultifactorial diseaseof thetearsandocularsurface
that results in symptomsof discomfort,visual disturbance,
andtear film instability with potential damageto theocular
surface.It is accompanied byincreasedosmolarity of the
tearfilm andinflammation of theocularsurface.”
Dry Eye is more than a red eye.
6
Dry Eye
Affects Quality of Life
7
Lacrimal
Glands
Secretomotor
Nerve Impulses
Tears Support and Maintain
Ocular Surface
Ocular Surface
Neural Stimulation
The Healthy Eye
Normal tearing
depends on a
neuronal feedback loop
8
Lacrimal Glands:
• Neurogenic
Inflammation
• T-cell Activation
• Cytokine Secretion into
Tears
Interrupted Secretomotor
Nerve Impulses
Tears Inflame Ocular Surface
Cytokines
Disrupt Neural Arc
Inflammation disrupts
normal neuronal
control of tearing
9
Dry Eye Disease: An Immune-Mediated
Inflammatory Disorder
10
Multiple Factors in Dry Eye
•Transientdiscomfort
•Maybestimulated by
environmentalconditions
•Inflammation andocular
surfacedamage
•Altered tear film composition
11
Role of Inflammation
in Chronic Dry Eye
•Inflammation maybepresent butnotclinically apparent
•Cycleofinflammation anddysfunction
•If untreated, inflammation candamagelacrimalglandand
ocular surface
• Consequences:
•Lowertearproduction
•Altered corneal barrier function
Healthy Tears
• Acomplexmixtureof
proteins, mucin, and
electrolytes
•Antimicrobial proteins:
Lysozyme,lactoferrin
•Growth factors &
suppressorsof
inflammation: EGF,IL-1RA
•Soluble mucinsecreted by
goblet cells for viscosity
•Electrolytes for proper
osmolarity
12
Tears in Chronic Dry Eye
• Decreasein manyproteins
• Decreased growth factor
concentrations
• Altered cytokine balance
promotes inflammation
• Soluble mucin5ACgreatly
decreased
• Dueto goblet cell loss
• Impacts viscosity of
tear film
• Proteases activated
• Increased electrolytes
13
14
Who Is Likely to Have Dry Eye?
How Do We Diagnose It?
Dry Eye: Multifactorial nature
Elderly woman
Contact lens
user
Post
menopausal
Taking
glaucoma
medications
Working for long
hours in front of
computer
Air-conditioned
environment
15
Patient Types with High Incidence of
Dry Eye Disease
•Womenaged50orolder
•Womenusing postmenopausalhormone
replacement therapy
•Thosewith ocular co-morbidities –
xerophthalmia, cicatrical pemphigoid,
atopic keratoconjunctivitis, ocular rosacea
•Contactlens wearers
•Smokers
16
17
Dry Eye Disease: Predisposing Factors
•Ageing
•Menopause- DecreasedAndrogens
•Allergy Response
•EnvironmentalStresses
• Contact LensWear
• Wind
• Air Pollution
•OcularSurgery(LASIK,CornealTransplant)
•Medications
– LowHumidity: Heating/AC
– Lackof Sleep
– Useof ComputerTerminals
Medications That May Contribute
to Dry Eye Disease
18
•Systemic
•Anti-hypertensives
•Anti-androgens
•Anti-cholinergics
•Antidepressants
•CardiacAnti-arrhythmic Drugs
•Parkinson’s DiseaseAgents
•Antihistamines
Topical
– Preservatives in
Tears
Dry Eye Disease:
Autoimmune Triggers
19
•SystemicAutoimmunity
•RheumatoidArthritis
•Lupus
•Sjögren’s Syndrome
•Graftvs. HostDisease
•All canresult in immune-mediated inflammation in theeye.
•Inflammatory mediatorssecreted into tears.
•Promote inflammation of ocular surface.
Environment
Medications
Contact Lens
Surgery
Rheumatoid
Arthritis
Lupus
Sjögren’s
Graft vs Host
Postmenopause
Meibomian
Gland Disease
Symptoms of Ocular Surface Disease
Inflammation
Tear
Deficiency/
Instability
Irritation
Current Triggers of Dry Eye Disease
20
21
22
Dry Eye Disease Symptoms
23
•Discomfort
•Dryness
•Burning,Stinging
•Foreign-BodySensation
•Gritty Feeling, Stickiness
•Blurry Vision
•Photophobia,Itching,
•Redness
Note:Symptomsseldomcorrelate with clinical signs
Slitlamp
Fluorescein
Dye Stain
Mild Severe
Clinical Presentation Can Vary in Severity
24
25
Slit lamp examination
•Increaseddebris/mucinstrandsin tearfilm
•Inspectionof tearmeniscusat lid margin.
•Normalthickness– 1mm,convex.
• <0.5mm– teardeficiency.
•In severecases– Marginaltearmeniscusis
concave,small&absent.
Filaments ( comma shaped) over corneal surface which move
on blinking
26
Mucous plaques – semi-transparent, white to grey, slightly
elevated lesions
Stain with rose bengal.
27
•Bulbarconjunctival vessels maybedilated  RedEye
•Cornealsurface– irregularity/ dryareas.
•Blinking – incomplete/infrequent.
•Meibomian glanddysfunction/ blepharitis.
28
29
Diagnostic Tests
•Appropriatechoiceof testhelpsthe clinicianto
arriveat anaccuratediagnosisaswell asfor
individualizationof therapy.
30
1. Basic Secretion Test
•Purpose– to measurebasal secretion byeliminating
reflex tearing.
•<5mm hyposecretion.
31
2. Schirmer’s Test I
•Purpose– measurementof thetotal (reflex +basal) tear
secretion.
•Eyesshouldnotbemanipulated before starting this test.
32
Schirmer Test
33
•Normalwetting
•DryEye
•Mild
•Moderate
•Severe
10-15mm
9-14mm
4-8mm
<4mm
34
35
Schirmer Test II
•Purpose– to ascertainreflexsecretion.
•Measuredafter 2minutes.
•After Stripsareplacedin eye un-anaeasthetized
nasalmucosais irritated.
•Lessthan15mmfailureof reflex secretion.
36
Rose Bengal staining
•Purpose- to ascertainindirectly, thepresence
of reducedtear volumebythedetectionof
damagedepithelialcells.
•Usefulin earlystagesof conjunctivitis sicca
andkeratoconjunctivitis siccasyndrome.
Rose Bengal Staining
• Positive test – show triangular stipple staining of nasal and
temporal bulbar conjunctiva in the interpalpebral area &possible
punctate staining of thecornea (esp. lower 2/3rd).
37
38
Rose Bengal Staining
•Falsepositive –
•Chronicconjunctivitis
•Acutechemicalconjunctivitis, secondaryto hair spray
useanddrugssuchastetracaine &cocaine
•Exposurekeratitis
•Superficial punctatekeratitis, secondaryto toxic or
idiopathic phenomena.
•Foreignbodiesin conjunctiva.
Modified van Bijsterveld conjunctival rose bengal grading map.
The density of rose bengal staining is recorded on a scale of 0-3 for
each of 6 areas of the conjunctiva, and then summed for each eye.
39
Fluoroscein Dye Test
40
Tear film Break-up time (BUT)
• Timeofappearanceof first dryspotfromthelast
blink.
• Testsfor stabilityof tearfilm.
41
42
43
Tear film Break-up time (BUT)
•Wettingtime>20s NormalTearfilm stability.
•BUTAveragesb/w25-30sin Normalindividuals.
•Women<Men
•Lessin elderly
•BUT<10s significant tear film instability.
NEI Workshop grading
Efron Scale
• Grade 0 = no staining
• Grade 1 = trace staining
• Grade 2 = mild staining
• Grade 3 = moderate
staining
• Grade 4 = severe
staining
44
45
Other tests
• Practical Double Vital Staining for Ocular Examination
• Corneal Residence TimeTestorTearClearance Rate(TCR)
• TearFunction Index
• TearFilm Osmolarity Test
• TearLactoferrin Test
• TearLysozymeTest
• Impression Cytology
• Biopsy of LabialAccessorySalivary Glands
• Ocular Ferning Test
Tear Film Osmolarity Test
•TearSamplesarecollectedwith hand-drawnmicropippete
from inferior marginal tear strip, without disturbing the
ocular surface.
•Tearosmolarity is determined byafreezing point
depressionosmometer.
•Normal– 295to 309mOsm/litre
•Elevatedin DryEyes.
46
47
Impression Cytology
•Todeterminethegoblet cell density of bulbar &palpebral
conjunctiva.
•Astrip of filter paperis gently pressedagainstthebulbar
&palpebral conjunctiva with aglass end.
•Staining with Schiff’s agent&counterstainingwith
haemotoxylin graded with microscope.
•DryEyes ↓ gobletcell counts.
DEWS Dry eye severity grading scheme
Dry Eye Severity
Level
48
1 2 3 4
Discomfort,
severity
& frequency
Mild and/or
episodic;
occurs under
environmental
stress
Moderate
episodic or
chronic, stress or
no
stress
Severe frequent
or constant
without stress
Severe and/or
disabling
and constant
Visual symptoms None or episodic
mild fatigue
Annoying and/or
activity-limiting
episodic
Annoying,
chronic
and/or constant,
limiting activity
Constant and/or
possibly disabling
Conjunctival
injection
None to mild None to mild +/- +/++
Conjunctival
staining
None to mild Variable Moderate to
marked
Marked
Corneal staining
severity/location
None to mild Variable Marked central Severe punctuate
erosions
49
Dry Eye Severity
Level 1 2 3 4
Corneal/tear
signs
None to mild Mild debris,
↓ meniscus
Filamentary
keratitis,
mucus clumping,
increased tear
debris
Filamentary
keratitis,
mucus clumping,
increased tear
debris, ulceration
Lid/meibomian
glands
MGD variably
present
MGD variably
present
Frequent Trichiasis,
keratinization,
symblepharon
TBUT (sec) Variable ≤ 10 ≤ 5 Immediate
Schirmer score
(mm/5 min)
Variable ≤ 10 ≤ 5 ≤ 2
50
Left Untreated, Chronic Dry Eye
May Become a Progressive Disorder
•Patients suffering from dry eye disease may move
between severity levels and can become worse, if
untreated.
•Disease management options can be adjusted for
individualpatientsdependingondiseaseseverity
51
Management
52
Aims of Treatment
•Relieve discomfort
•Provide smoothoptical surface
•Preventstructural ocular surface damage
53
Modalities of treatment
•Preservation of existing tears
•Reduction of tear drainage
•Tearsubstitutes
•Treatanyother associated eyediseasewhich
predisposestodry eye
•Otheroptions
54
Preservation of existing tears
• Environmental modifications suchashumidification,
avoidanceof wind/dustyorsmokyenvironment,avoid
central heating
• Lifestyle/workplace modifications
• taking regular breaks fromreading or computeruse
• lowering computermonitor below eyelevel
• increasing blink/fast blinking exercise
• discontinuing medications that exacerbate DED
•Asmall lateral tarsorrhaphy– useful in incomplete lid
closure.
55
Reduction of tear drainage
Donebypunctualocclusion
•Preservesnaturaltears &prolongseffectof
artificial tears
•Greatestvaluein severeKCSwhohavenot
respondedto frequent useof topicaltreatment.
•Maybe–
o Shorttermocclusion
o Permanentocclusion
Temporary occlusion
•Collagenplugsareused.
•Dissolve in 1-2weekstime.
•Initially all four puncta are
occluded
•If epiphoraoccurs,thenupper
twoplugsremoved
If patient is asymptomatic,
thenlower punctaare
permanently occluded
56
57
Reversible occlusion
•Reversibleprolongedocclusionwithsilicone/long
actingcollagenplugs(that dissolvein 2-6wks).
•Problems–
•Extrusion
•Granulomaformation
•Distalmigration.
Permanent occlusion
• Donein severeKCS&
repeated Schirmer <2mm
• Should not bedonein –
• Patients whodevelop
epiphora following
temporary occlusion of
lower puncta
• Youngpatients as
their tear production
tends tofluctuate
• Donebycautery
58
Tear substitutes
•ArtificialTearDropsused.
•Stabilize&thickenpre-cornealtearfilm .
•Prolongstear film B.U.T.
•Keepsocular surfacewet&lubricated.
•Helpsto repairocular surfacedamage
•Keepsocular surfacesmooth
59
60
Tear substitutes
• Drops- Frequent instillation is required
Preservative free drops arebetter
• Gels– Consists of carbomers
Less frequent instillation required
• Ointments– Contains petroleum mineral oil &usedat bedtime
Mucolyticagents– 5%acetylcysteine dropsQIDto disperse
corneal filaments &mucousplaques.
61
Eye Drops
• Cellulose derivatives –
o Hydroxypropyl methylcellulose
o Carboxymethylcellulose [moreuseful in lipid or mucous
deficiency]
o Appropriate for mild cases.
• Polyvinyl alcohol – Better in aqueous deficiency
o Dose
 QIDin mild cases
 ½hrly – 2hrly in severecases
• Povidone
• Sodiumchloride
• Hypromellose
• Sodium hyaluronate
• Polyethylene and propylene glycol
62
Treatment of associated diseases
•Meibomian glanddisease/ Blepharitis –
•Lidhygiene – warmcompresses,lid massage
•Lid scrubs
•SystemicDoxycycline/Azithromycin/ Roxitromycin
•Correctionof eyelid abnormalities – blepharoptosis,
lagophthalmos
63
Other options
• Topicalcyclosporine[0.05%,0.1%]
• Reducescell-mediatedinflammationoflacrimaltissue
 increasein gobletcells,reversalofsquamous
metaplasiaofconjunctiva.
• Oralcholinergicagents(M3)like pilocarpine, cevimeline
• Effectivein xerostomia&about40%of KCSpatients
alsoobtainrelief
• Botulinumtoxininjectiontoorbicularis muscle– controls
blepharospasmin severedryeye.
• Sub-mandibularglandtransplantation– for extremedry eye.
64
The DEWS treatment recommendations were based on the
modified severity grading (based on severity level)
Level 1:
Education and counselling
Environmental management
Elimination of offending systemic medications
Preserved tear substitutes, allergy eye drops
Level 2:
If Level 1 treatments are inadequate, add:
Unpreserved tears, gels, ointments
Steroids
Cyclosporine A
Secretagogues
Nutritional supplements
65
Level 3:
If Level 2 treatments are inadequate, add:
Tetracyclines
Autologous serum tears
Punctal plugs (after control of inflammation)
Level 4:
If Level 3 treatments are inadequate, add:
Topical vitamin A
Contact lenses
Acetylcysteine
Moisture goggles
Surgery-Amniotic Membrane Transplanatation
Limbal stem cell graft
Keratoplasty
66
Thank You

More Related Content

Similar to Dry eye new power point presentation edited.pptx

Similar to Dry eye new power point presentation edited.pptx (20)

Dry eye ppt by dr dildar
Dry eye ppt by dr dildarDry eye ppt by dr dildar
Dry eye ppt by dr dildar
 
Dry eye
Dry eye Dry eye
Dry eye
 
Dry eye
Dry eyeDry eye
Dry eye
 
Dry Eye : Recent Trend- a review
Dry Eye : Recent Trend- a reviewDry Eye : Recent Trend- a review
Dry Eye : Recent Trend- a review
 
Dry eye disease
Dry eye diseaseDry eye disease
Dry eye disease
 
MGD...Unplugged
MGD...UnpluggedMGD...Unplugged
MGD...Unplugged
 
Dry eye: A Multifactorial Disease
Dry eye: A Multifactorial DiseaseDry eye: A Multifactorial Disease
Dry eye: A Multifactorial Disease
 
Dry eye sameer
Dry eye  sameerDry eye  sameer
Dry eye sameer
 
Dry eye
Dry eyeDry eye
Dry eye
 
Dry eye syndrome
Dry eye syndromeDry eye syndrome
Dry eye syndrome
 
Dry Eye Created by Art
Dry Eye Created by ArtDry Eye Created by Art
Dry Eye Created by Art
 
Dry eye pathology
Dry eye pathologyDry eye pathology
Dry eye pathology
 
Dry eyes
Dry eyesDry eyes
Dry eyes
 
TH036-Bloom.ppt
TH036-Bloom.pptTH036-Bloom.ppt
TH036-Bloom.ppt
 
Dry eye syndrome
Dry eye syndromeDry eye syndrome
Dry eye syndrome
 
Eyelid Infections & Blepharitis Dr. Prabhat Devkota.pptx
Eyelid Infections  & Blepharitis Dr. Prabhat Devkota.pptxEyelid Infections  & Blepharitis Dr. Prabhat Devkota.pptx
Eyelid Infections & Blepharitis Dr. Prabhat Devkota.pptx
 
Microbial Diseases of the Eye
Microbial Diseases of the EyeMicrobial Diseases of the Eye
Microbial Diseases of the Eye
 
Dry eye
Dry eyeDry eye
Dry eye
 
infection of eye and cataract.pdf
infection of eye and cataract.pdfinfection of eye and cataract.pdf
infection of eye and cataract.pdf
 
Blepharitis
BlepharitisBlepharitis
Blepharitis
 

Recently uploaded

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 

Recently uploaded (20)

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 

Dry eye new power point presentation edited.pptx

  • 2. 2 Learning Objectives Attheendofthisclassthestudentsshallbeableto: •Definedryeyedisease. • Understand predisposing andaetiological factors responsible for dryeyedisease • Comprehendclinical features andtests for theabove condition • Understand fundamentals of managing dryeye depending ontheseverity of disease
  • 3. 3 What is Dry Eye Disease? •Dry eyedisease(DED)is acondition caused by many factors that result in inflammation of theeyeandtear-producingglands. •Inflammationcandecreasetheability of the eyeto producenormaltearsthatprotectthe surfaceoftheeyeandkeepit moistand lubricated.
  • 4. 4 Definition Dryeyeis notatrivial complaint. It cancausesignificant discomfort andaffect quality of life significantly.  In 1995theNational EyeInstitute defined dryeye disease(DED) as“ adisorderof thetear film dueto tear deficiencyorexcessivetear evaporation whichcauses damageto theinterpalpebral ocular surfaceandis associated with symptomsof ocular discomfort”.
  • 5. 5 Definition In 2007theInternational DryEyeWorkshop defined it as “ amultifactorial diseaseof thetearsandocularsurface that results in symptomsof discomfort,visual disturbance, andtear film instability with potential damageto theocular surface.It is accompanied byincreasedosmolarity of the tearfilm andinflammation of theocularsurface.”
  • 6. Dry Eye is more than a red eye. 6
  • 8. Lacrimal Glands Secretomotor Nerve Impulses Tears Support and Maintain Ocular Surface Ocular Surface Neural Stimulation The Healthy Eye Normal tearing depends on a neuronal feedback loop 8
  • 9. Lacrimal Glands: • Neurogenic Inflammation • T-cell Activation • Cytokine Secretion into Tears Interrupted Secretomotor Nerve Impulses Tears Inflame Ocular Surface Cytokines Disrupt Neural Arc Inflammation disrupts normal neuronal control of tearing 9 Dry Eye Disease: An Immune-Mediated Inflammatory Disorder
  • 10. 10 Multiple Factors in Dry Eye •Transientdiscomfort •Maybestimulated by environmentalconditions •Inflammation andocular surfacedamage •Altered tear film composition
  • 11. 11 Role of Inflammation in Chronic Dry Eye •Inflammation maybepresent butnotclinically apparent •Cycleofinflammation anddysfunction •If untreated, inflammation candamagelacrimalglandand ocular surface • Consequences: •Lowertearproduction •Altered corneal barrier function
  • 12. Healthy Tears • Acomplexmixtureof proteins, mucin, and electrolytes •Antimicrobial proteins: Lysozyme,lactoferrin •Growth factors & suppressorsof inflammation: EGF,IL-1RA •Soluble mucinsecreted by goblet cells for viscosity •Electrolytes for proper osmolarity 12
  • 13. Tears in Chronic Dry Eye • Decreasein manyproteins • Decreased growth factor concentrations • Altered cytokine balance promotes inflammation • Soluble mucin5ACgreatly decreased • Dueto goblet cell loss • Impacts viscosity of tear film • Proteases activated • Increased electrolytes 13
  • 14. 14 Who Is Likely to Have Dry Eye? How Do We Diagnose It?
  • 15. Dry Eye: Multifactorial nature Elderly woman Contact lens user Post menopausal Taking glaucoma medications Working for long hours in front of computer Air-conditioned environment 15
  • 16. Patient Types with High Incidence of Dry Eye Disease •Womenaged50orolder •Womenusing postmenopausalhormone replacement therapy •Thosewith ocular co-morbidities – xerophthalmia, cicatrical pemphigoid, atopic keratoconjunctivitis, ocular rosacea •Contactlens wearers •Smokers 16
  • 17. 17 Dry Eye Disease: Predisposing Factors •Ageing •Menopause- DecreasedAndrogens •Allergy Response •EnvironmentalStresses • Contact LensWear • Wind • Air Pollution •OcularSurgery(LASIK,CornealTransplant) •Medications – LowHumidity: Heating/AC – Lackof Sleep – Useof ComputerTerminals
  • 18. Medications That May Contribute to Dry Eye Disease 18 •Systemic •Anti-hypertensives •Anti-androgens •Anti-cholinergics •Antidepressants •CardiacAnti-arrhythmic Drugs •Parkinson’s DiseaseAgents •Antihistamines Topical – Preservatives in Tears
  • 19. Dry Eye Disease: Autoimmune Triggers 19 •SystemicAutoimmunity •RheumatoidArthritis •Lupus •Sjögren’s Syndrome •Graftvs. HostDisease •All canresult in immune-mediated inflammation in theeye. •Inflammatory mediatorssecreted into tears. •Promote inflammation of ocular surface.
  • 20. Environment Medications Contact Lens Surgery Rheumatoid Arthritis Lupus Sjögren’s Graft vs Host Postmenopause Meibomian Gland Disease Symptoms of Ocular Surface Disease Inflammation Tear Deficiency/ Instability Irritation Current Triggers of Dry Eye Disease 20
  • 21. 21
  • 22. 22
  • 23. Dry Eye Disease Symptoms 23 •Discomfort •Dryness •Burning,Stinging •Foreign-BodySensation •Gritty Feeling, Stickiness •Blurry Vision •Photophobia,Itching, •Redness Note:Symptomsseldomcorrelate with clinical signs
  • 24. Slitlamp Fluorescein Dye Stain Mild Severe Clinical Presentation Can Vary in Severity 24
  • 25. 25 Slit lamp examination •Increaseddebris/mucinstrandsin tearfilm •Inspectionof tearmeniscusat lid margin. •Normalthickness– 1mm,convex. • <0.5mm– teardeficiency. •In severecases– Marginaltearmeniscusis concave,small&absent.
  • 26. Filaments ( comma shaped) over corneal surface which move on blinking 26
  • 27. Mucous plaques – semi-transparent, white to grey, slightly elevated lesions Stain with rose bengal. 27
  • 28. •Bulbarconjunctival vessels maybedilated  RedEye •Cornealsurface– irregularity/ dryareas. •Blinking – incomplete/infrequent. •Meibomian glanddysfunction/ blepharitis. 28
  • 29. 29 Diagnostic Tests •Appropriatechoiceof testhelpsthe clinicianto arriveat anaccuratediagnosisaswell asfor individualizationof therapy.
  • 30. 30
  • 31. 1. Basic Secretion Test •Purpose– to measurebasal secretion byeliminating reflex tearing. •<5mm hyposecretion. 31
  • 32. 2. Schirmer’s Test I •Purpose– measurementof thetotal (reflex +basal) tear secretion. •Eyesshouldnotbemanipulated before starting this test. 32
  • 35. 35 Schirmer Test II •Purpose– to ascertainreflexsecretion. •Measuredafter 2minutes. •After Stripsareplacedin eye un-anaeasthetized nasalmucosais irritated. •Lessthan15mmfailureof reflex secretion.
  • 36. 36 Rose Bengal staining •Purpose- to ascertainindirectly, thepresence of reducedtear volumebythedetectionof damagedepithelialcells. •Usefulin earlystagesof conjunctivitis sicca andkeratoconjunctivitis siccasyndrome.
  • 37. Rose Bengal Staining • Positive test – show triangular stipple staining of nasal and temporal bulbar conjunctiva in the interpalpebral area &possible punctate staining of thecornea (esp. lower 2/3rd). 37
  • 38. 38 Rose Bengal Staining •Falsepositive – •Chronicconjunctivitis •Acutechemicalconjunctivitis, secondaryto hair spray useanddrugssuchastetracaine &cocaine •Exposurekeratitis •Superficial punctatekeratitis, secondaryto toxic or idiopathic phenomena. •Foreignbodiesin conjunctiva.
  • 39. Modified van Bijsterveld conjunctival rose bengal grading map. The density of rose bengal staining is recorded on a scale of 0-3 for each of 6 areas of the conjunctiva, and then summed for each eye. 39
  • 41. Tear film Break-up time (BUT) • Timeofappearanceof first dryspotfromthelast blink. • Testsfor stabilityof tearfilm. 41
  • 42. 42
  • 43. 43 Tear film Break-up time (BUT) •Wettingtime>20s NormalTearfilm stability. •BUTAveragesb/w25-30sin Normalindividuals. •Women<Men •Lessin elderly •BUT<10s significant tear film instability.
  • 44. NEI Workshop grading Efron Scale • Grade 0 = no staining • Grade 1 = trace staining • Grade 2 = mild staining • Grade 3 = moderate staining • Grade 4 = severe staining 44
  • 45. 45 Other tests • Practical Double Vital Staining for Ocular Examination • Corneal Residence TimeTestorTearClearance Rate(TCR) • TearFunction Index • TearFilm Osmolarity Test • TearLactoferrin Test • TearLysozymeTest • Impression Cytology • Biopsy of LabialAccessorySalivary Glands • Ocular Ferning Test
  • 46. Tear Film Osmolarity Test •TearSamplesarecollectedwith hand-drawnmicropippete from inferior marginal tear strip, without disturbing the ocular surface. •Tearosmolarity is determined byafreezing point depressionosmometer. •Normal– 295to 309mOsm/litre •Elevatedin DryEyes. 46
  • 47. 47 Impression Cytology •Todeterminethegoblet cell density of bulbar &palpebral conjunctiva. •Astrip of filter paperis gently pressedagainstthebulbar &palpebral conjunctiva with aglass end. •Staining with Schiff’s agent&counterstainingwith haemotoxylin graded with microscope. •DryEyes ↓ gobletcell counts.
  • 48. DEWS Dry eye severity grading scheme Dry Eye Severity Level 48 1 2 3 4 Discomfort, severity & frequency Mild and/or episodic; occurs under environmental stress Moderate episodic or chronic, stress or no stress Severe frequent or constant without stress Severe and/or disabling and constant Visual symptoms None or episodic mild fatigue Annoying and/or activity-limiting episodic Annoying, chronic and/or constant, limiting activity Constant and/or possibly disabling Conjunctival injection None to mild None to mild +/- +/++ Conjunctival staining None to mild Variable Moderate to marked Marked Corneal staining severity/location None to mild Variable Marked central Severe punctuate erosions
  • 49. 49 Dry Eye Severity Level 1 2 3 4 Corneal/tear signs None to mild Mild debris, ↓ meniscus Filamentary keratitis, mucus clumping, increased tear debris Filamentary keratitis, mucus clumping, increased tear debris, ulceration Lid/meibomian glands MGD variably present MGD variably present Frequent Trichiasis, keratinization, symblepharon TBUT (sec) Variable ≤ 10 ≤ 5 Immediate Schirmer score (mm/5 min) Variable ≤ 10 ≤ 5 ≤ 2
  • 50. 50 Left Untreated, Chronic Dry Eye May Become a Progressive Disorder •Patients suffering from dry eye disease may move between severity levels and can become worse, if untreated. •Disease management options can be adjusted for individualpatientsdependingondiseaseseverity
  • 52. 52 Aims of Treatment •Relieve discomfort •Provide smoothoptical surface •Preventstructural ocular surface damage
  • 53. 53 Modalities of treatment •Preservation of existing tears •Reduction of tear drainage •Tearsubstitutes •Treatanyother associated eyediseasewhich predisposestodry eye •Otheroptions
  • 54. 54 Preservation of existing tears • Environmental modifications suchashumidification, avoidanceof wind/dustyorsmokyenvironment,avoid central heating • Lifestyle/workplace modifications • taking regular breaks fromreading or computeruse • lowering computermonitor below eyelevel • increasing blink/fast blinking exercise • discontinuing medications that exacerbate DED •Asmall lateral tarsorrhaphy– useful in incomplete lid closure.
  • 55. 55 Reduction of tear drainage Donebypunctualocclusion •Preservesnaturaltears &prolongseffectof artificial tears •Greatestvaluein severeKCSwhohavenot respondedto frequent useof topicaltreatment. •Maybe– o Shorttermocclusion o Permanentocclusion
  • 56. Temporary occlusion •Collagenplugsareused. •Dissolve in 1-2weekstime. •Initially all four puncta are occluded •If epiphoraoccurs,thenupper twoplugsremoved If patient is asymptomatic, thenlower punctaare permanently occluded 56
  • 57. 57 Reversible occlusion •Reversibleprolongedocclusionwithsilicone/long actingcollagenplugs(that dissolvein 2-6wks). •Problems– •Extrusion •Granulomaformation •Distalmigration.
  • 58. Permanent occlusion • Donein severeKCS& repeated Schirmer <2mm • Should not bedonein – • Patients whodevelop epiphora following temporary occlusion of lower puncta • Youngpatients as their tear production tends tofluctuate • Donebycautery 58
  • 59. Tear substitutes •ArtificialTearDropsused. •Stabilize&thickenpre-cornealtearfilm . •Prolongstear film B.U.T. •Keepsocular surfacewet&lubricated. •Helpsto repairocular surfacedamage •Keepsocular surfacesmooth 59
  • 60. 60 Tear substitutes • Drops- Frequent instillation is required Preservative free drops arebetter • Gels– Consists of carbomers Less frequent instillation required • Ointments– Contains petroleum mineral oil &usedat bedtime Mucolyticagents– 5%acetylcysteine dropsQIDto disperse corneal filaments &mucousplaques.
  • 61. 61 Eye Drops • Cellulose derivatives – o Hydroxypropyl methylcellulose o Carboxymethylcellulose [moreuseful in lipid or mucous deficiency] o Appropriate for mild cases. • Polyvinyl alcohol – Better in aqueous deficiency o Dose  QIDin mild cases  ½hrly – 2hrly in severecases • Povidone • Sodiumchloride • Hypromellose • Sodium hyaluronate • Polyethylene and propylene glycol
  • 62. 62 Treatment of associated diseases •Meibomian glanddisease/ Blepharitis – •Lidhygiene – warmcompresses,lid massage •Lid scrubs •SystemicDoxycycline/Azithromycin/ Roxitromycin •Correctionof eyelid abnormalities – blepharoptosis, lagophthalmos
  • 63. 63 Other options • Topicalcyclosporine[0.05%,0.1%] • Reducescell-mediatedinflammationoflacrimaltissue  increasein gobletcells,reversalofsquamous metaplasiaofconjunctiva. • Oralcholinergicagents(M3)like pilocarpine, cevimeline • Effectivein xerostomia&about40%of KCSpatients alsoobtainrelief • Botulinumtoxininjectiontoorbicularis muscle– controls blepharospasmin severedryeye. • Sub-mandibularglandtransplantation– for extremedry eye.
  • 64. 64 The DEWS treatment recommendations were based on the modified severity grading (based on severity level) Level 1: Education and counselling Environmental management Elimination of offending systemic medications Preserved tear substitutes, allergy eye drops Level 2: If Level 1 treatments are inadequate, add: Unpreserved tears, gels, ointments Steroids Cyclosporine A Secretagogues Nutritional supplements
  • 65. 65 Level 3: If Level 2 treatments are inadequate, add: Tetracyclines Autologous serum tears Punctal plugs (after control of inflammation) Level 4: If Level 3 treatments are inadequate, add: Topical vitamin A Contact lenses Acetylcysteine Moisture goggles Surgery-Amniotic Membrane Transplanatation Limbal stem cell graft Keratoplasty